CompanyScope

Celestica Inc. revenue by year

Ticker CLS · SEC CIK 1030894 · Latest fiscal year ended Dec 31, 2025

Over the 4 fiscal years shown, revenue went from $7.25B (year ended Dec 31, 2022) to $12.39B (year ended Dec 31, 2025), a compound annual growth rate of 19.6%. The fastest growth was +28.5% in the year ended Dec 31, 2025; the weakest year was +9.8% (year ended Dec 31, 2023).

$0$5B$10B$15BDec 2022: $7.25BDec 2023: $7.96BDec 2024: $9.65BDec 2025: $12.39BDec 2022Dec 2023Dec 2024Dec 2025
Celestica Inc. revenue by fiscal year, USD. Hover a bar for the exact figure.

Annual revenue

Fiscal year endedRevenue (USD)ChangeXBRL conceptReported in
Dec 31, 2025$12.39B+28.5%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 27, 2026
Dec 31, 2024$9.65B+21.2%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 27, 2026
Dec 31, 2023$7.96B+9.8%RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Feb 27, 2026
Dec 31, 2022$7.25B—RevenueFromContractWithCustomerExcludingAssessedTax10-K filed Mar 3, 2025

Quarterly revenue

Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.

QuarterRevenue (USD)vs same quarter a year earlierSource
3 months ended Sep 30, 2026$5.83B+82.5%10-Q filed Oct 26, 2026
3 months ended Jun 30, 2026$4.70B+62.4%10-Q filed Jul 27, 2026
3 months ended Mar 31, 2026$4.05B+52.8%10-Q filed Apr 27, 2026
3 months ended Sep 30, 2025$3.19B+27.8%10-Q filed Oct 26, 2026
3 months ended Jun 30, 2025$2.89B+21.0%10-Q filed Jul 27, 2026
3 months ended Mar 31, 2025$2.65B+19.9%10-Q filed Apr 27, 2026
3 months ended Sep 30, 2024$2.50B—10-Q filed Oct 27, 2025
3 months ended Jun 30, 2024$2.39B—10-Q filed Jul 28, 2025

Source: SEC EDGAR XBRL company facts for CIK 1030894 (raw data). Most recent filing in this dataset: 10-Q filed Oct 26, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.